Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

Go back to Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
(NASDAQ: UNCY) Delayed: 8.02 +0.15 (1.91%)
Previous Close $7.87    52 Week High
Open $7.76    52 Week Low
Day High $8.44    P/E N/A 
Day Low $7.72    EPS
Volume 1,741,918